| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
|
Yardley, Denise A.
|
|
|
20 |
2 |
p. 89-97
|
artikel
|
| 2 |
A Predictor of Early Disease Recurrence in Patients With Breast Cancer Using a Cell-free RNA and Protein Liquid Biopsy
|
Lasham, Annette
|
|
|
20 |
2 |
p. 108-116
|
artikel
|
| 3 |
Breast Cancer Provider Interval Length in Fukushima, Japan, After the 2011 Triple Disaster: A Long-Term Retrospective Study
|
Ozaki, Akihiko
|
|
|
20 |
2 |
p. e127-e150
|
artikel
|
| 4 |
Breast Reconstruction After Resection of Bilateral Giant Phyllodes Tumors: Two Separate Deep Inferior Epigastric Perforator Flaps From One Donor Site
|
Tu, Chin-Wen
|
|
|
20 |
2 |
p. e188-e191
|
artikel
|
| 5 |
Clinical Characteristics and Outcomes of Single Versus Double Hormone Receptor–Positive Breast Cancer in 2 Large Databases
|
Li, Zhiyu
|
|
|
20 |
2 |
p. e151-e163
|
artikel
|
| 6 |
Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor–Positive Early Breast Cancer
|
Yoo, Shin Hye
|
|
|
20 |
2 |
p. 98-107.e1
|
artikel
|
| 7 |
Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients
|
Cutuli, Bruno
|
|
|
20 |
2 |
p. e164-e172
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
20 |
2 |
p. A3
|
artikel
|
| 9 |
Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer
|
Takahashi, Yuko
|
|
|
20 |
2 |
p. 117-124.e4
|
artikel
|
| 10 |
Galactogram Grading System for Identifying Breast Cancer With Nipple Discharge
|
Jiang, Liyu
|
|
|
20 |
2 |
p. e214-e219
|
artikel
|
| 11 |
High Oncotype Recurrence Score, Hereditary Cancer Syndromes, and Referral for Genetic Testing
|
Goel, Arun Kumar
|
|
|
20 |
2 |
p. e196-e197
|
artikel
|
| 12 |
Incidence and Management of Diarrhea With Adjuvant Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
|
Bines, José
|
|
|
20 |
2 |
p. 174-181.e3
|
artikel
|
| 13 |
MicroRNA-4472 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer by Targeting RGMA and Inducing EMT
|
Li, Yan
|
|
|
20 |
2 |
p. e113-e126
|
artikel
|
| 14 |
Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections
|
Fountzilas, Elena
|
|
|
20 |
2 |
p. 152-159
|
artikel
|
| 15 |
Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2–negative Metastatic Breast Cancer
|
Smith II, John
|
|
|
20 |
2 |
p. 160-167
|
artikel
|
| 16 |
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022
|
Freedman, Rachel A.
|
|
|
20 |
2 |
p. 145-151.e2
|
artikel
|
| 17 |
Predicting Thrombocytopenia in Patients With Breast Cancer Treated With Ado-trastuzumab Emtansine
|
Modi, Natansh D.
|
|
|
20 |
2 |
p. e220-e228
|
artikel
|
| 18 |
Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer
|
Wu, Wanbo
|
|
|
20 |
2 |
p. 131-144.e3
|
artikel
|
| 19 |
Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Compared With Letrozole: Analysis From PALOMA-2
|
Rugo, Hope S.
|
|
|
20 |
2 |
p. e173-e180
|
artikel
|
| 20 |
Radiotherapy Utilization for Patients Over Age 60 With Early Stage Breast Cancer
|
Paulsson, Anna K.
|
|
|
20 |
2 |
p. 168-173
|
artikel
|
| 21 |
Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score
|
Casasanta, Nicole
|
|
|
20 |
2 |
p. 125-130
|
artikel
|
| 22 |
Response to Letter to the Editor: High Oncotype DX Recurrence Score, Hereditary Cancer Syndromes, and Referral for Germline Genetic Testing
|
Casasanta, Nicole
|
|
|
20 |
2 |
p. e198-e199
|
artikel
|
| 23 |
Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib
|
Guillaume, Zoé
|
|
|
20 |
2 |
p. e192-e195
|
artikel
|
| 24 |
Table of Contents
|
|
|
|
20 |
2 |
p. A5-A9
|
artikel
|
| 25 |
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study
|
Conte, Benedetta
|
|
|
20 |
2 |
p. e181-e187
|
artikel
|
| 26 |
The Impact of Locoregional Treatment on Survival in Patients With Metastatic Breast Cancer: A National Cancer Database Analysis
|
Kim, Kristine N.
|
|
|
20 |
2 |
p. e200-e213
|
artikel
|
Tijdschrift beschrijving